-+ 0.00%
-+ 0.00%
-+ 0.00%

United Therapeutics Chairperson, CEO Martine Rothblatt disposes of shares worth $4.91 million

PUBT·10/06/2026 20:32:55
Listen to the news
United Therapeutics Chairperson, CEO Martine Rothblatt disposes of shares worth $4.91 million
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 117.76 on Oct. 5, 2026.
  • Family trust sold 8,500 shares the same day at weighted-average prices ranging from USD 536.2579 to USD 546.6322.
  • Trust holdings fell to 324,443 shares following the sales.
  • Trust-held stock options rose to 299,910 following the exercise.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000157), on October 06, 2026, and is solely responsible for the information contained therein.